Interestingly, the effect of LSD1 inhibitors on the scaffolding function of LSD1 may be limited mostly to the covalently acting tranylcypromine derivatives which makes them ideal as drug candidates for the treatment of AML (28). Here, KDM1A is linked to acute myeloid leukemia.